Genetic Variations May Help Identify Best Candidates for Preventive Breast Cancer Drugs

Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found.
Source: News from Mayo Clinic - Category: Databases & Libraries Authors: Source Type: news